{
    "nctId": "NCT00721565",
    "briefTitle": "An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)",
    "officialTitle": "An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 49,
    "primaryOutcomeMeasure": "change in physical activity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female breast cancer patients between the ages of 18 and 70 years of age with a diagnosis of Stage I, II, or IIIA breast cancer who are currently taking aromatase inhibitors or selective estrogen receptor modulators for the next 8 months.\n* English speaking\n* Medical clearance for participation provided by primary care physicians\n* If the patient has undergone a surgical procedure, must be at least 6 weeks post-procedure\n\nExclusion Criteria:\n\n* Diagnosis of dementia or organic brain syndrome\n* Medical, psychological or social characteristic that would interfere with ability to fully participate in program activities and assessments (e.g., psychosis, schizophrenia, etc.)\n* Contraindication to participation in a regular physical activity program.\n* Metastatic or recurrent disease\n* Inability to ambulate\n* Engaged in \\>/= 60 minutes of vigorous physical activity or \\>/= 150 minutes of moderate plus vigorous physical activity per week during the past month.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}